A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.

NCT01408355 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: PF-06273588
DRUG: PF-06273588

Sponsor

Pfizer